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I~  Two-year outcomes of behavior and nutrition treatment for young 
children with Cystic Fibrosis 
S.W Powers 1, C. Piazza-Waggoner 1 , K.A. Driscoll 1 , J.S. Jones 2, J. Acton 3, 
C. Daines 3. 1Division of Behavioral Medicine & Clinical Psychology, Cincinnati 
Children ~' Hospital Medical Cente~ 2Division of Developmental & Behavioral 
Pediatrics, Greenville Hospital System Children ~' Hospital; 3 Cystic Fibrosis 
Cente~ Cincinnati Children ~' Hospital Medical Cente~ Cincinnati, USA 
Aims: To evaluate whether changes in energy intake and growth velocity due to 
behavior and nutrition treatment (BEH) for young children with CF were maintained 
at 2-yr follow-up (f-up). 
Methods: Two-yr f-up data for 9 subjects who completed an 8-week BEH interven- 
tion, which included nutrition counseling and parental child behavior management 
training. For f-up assessments hree 24-hour recall diet diaries and height (ht) 
& weight (wt) were obtained. Average daily energy intake and growth velocity 
(ht&wt) were outcome variables. Velocity was benchmarked against expected 
velocities for a same age child without CF at the 50th percentile (US 2000 Center 
for Disease Control growth charts). 
Results: The average daily energy intake was 2,589±519 kcal/day at the 2-yr f-up. 
This compares favorably to data from post-treatment (2151±301 kcal/day). Pre- 
treatment intake was 1,381±198kcal/day. Subjects exceeded the goal of 120% 
RDA/day for energy intake at 2-yr f-up. 
The average wt velocity was 4.94/2-yr (Median: 4.6). Seven of 9 subjects were above 
benchmark. The average ht velocity was 15.8/2-yr (Median: 15.7). All subjects were 
above benchmark. 
Conclusions: Upon returning to standard care, young children with CF who 
received BEH continue to maintain clinically significant increases in energy intake, 
and demonstrate patterns of normal growth at 2-yr post-treatment. Findings uggest 
this intervention is durable and families are able to continue to implement skills 
and knowledge acquired uring treatment. 
Supported by US National Institutes of Health. 
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1~ Anemia in adult patients with cystic fibrosis (CF) 
S. Hansen 1 , L. Houghton 2, A. Freitag 1, R. Labiris 1 . 1Hamilton Health Science, 
McMaster University, Hamilton, ON; 2Acadia University Woljbille, NS, Canada 
Aim: To determine the prevalence of anemia in adult patients with CE 
Method: Sixty pts (mean age 28y; range 19 53y) had ferritin, iron, TIBC, 
transferrin saturation (TS), hemoglobin (Hb), MCV, RBC folate, B12, C-reactive 
protein (CRP) and erythrocyte sedimentation rate (ESR) measurements. All pts 
are prescribed 2 ADEK tablets/day containing 0.2 mg folic acid (FA) and 12 gg 
cyanocobalamin per tablet. Results are reported as mean±SD. 
Results: Mean Hb was 140±14.1 g/L with normal MCV (86.9±4.4 fL) reported in 
55/60 (91.7%) pts. Serum iron (11 ± 5.1 gmol/L) was < 12 gmol/L in 36/60 (60%) 
yet, TIBC remained normal. Serum ferritin concentrations (35.5± 37.1 gg/L) were 
low with 13/60 (21.7%) pts exhibiting concentrations <23 gg/L. The inflammatory 
markers CRP and ESR were elevated in 78% (47/60) and 66.7% (40/60) pts, 
respectively. TS < 16% indicative of Fe deficiency was noted in 25/60 (41.7%) 
pts. Elevated B 12 (740.5±426.3 pmol/L) and RBC folate (1823±682 nmol/L) were 
reported in 45% (27/60) and 53.3% (32/60) pts, respectively. 
Conclusion: Chronic inflammation, as demonstrated by elevated CRP and ESR, is 
likely the cause of Fe deficiency anemia in adult CF pts. Elevated B12 and RBC 
folate are likely secondary to the provision of such within the ADEK multivitamin 
tablet. Canada's mandatory FA fortification of the food supply in 1998, has also 
contributed to significant blood folate improvements. Concern about exposure to 
excessive FA intake masking B 12 deficiency was not seen in our population. Newer 
concerns are emerging showing that unmetabolized FA in plasma due to excessive 
intake is associated with decreased NK cytotoxicity. These data suggest that further 
increases in supplemental FA should be prescribed with caution in the era of 
postfortification. 
l • A n  audit of the food provision for inpatients with Cystic Fibrosis 
J. Roberts, R. Richmond, H. Musson, A.M. Jones, A.K. Webb. Manchester Adult 
CF Centre, UK 
Introduction: During an inpatient stay nutrition is provided by four sources: 
hospital catering, ward snacks, enteral feeds/supplements and patient's own food. 
Complaints about inpatient food provision occur daily at the centre. To address 
the problem, quantitative and qualitative information about the food provision was 
collected. 
Aims: To determine: 
1. If patients are meeting their energy requirements during an inpatient stay. 
2. The percentage of their energy requirements provided by each source. 
3. Patient satisfaction with food provision. 
Methods: Food eaten by each patient was determined over three consecutive days 
using two methods: 
1. Three-day weighed food intakes (for food provided by catering) 
2. Three-day food diaries (for all other sources of food eaten). 
Patients also completed a questionnaire that assessed their satisfaction with inpatient 
food provision. Patients ex, age and body mass index (BMI) were noted. Energy 
intakes were calculated using Microdiet nutrient analysis oftware. Patient energy 
requirements were taken as 120% of the UK Estimated Average Requirement. 
Results: Nine patients completed the audit (six male). Mean (range) BMI 19.2 
(15.7 23.4). 5/9 patients met their energy requirements. The mean (range) en- 
ergy intake provided from each source (expressed as a percentage of energy 
requirements) is as follows: catering 48.8°/0 (6 84.3); ward snacks 4.4°/0 (0 14.4); 
feeds/supplements 19.1°/0 (0 86.7); own food 22.6°/0 (3.9 68.2). Satisfaction with 
food provision: 3/9 felt it was poor, 2/9 satisfactory and 4/9 good. 
Conclusion: Whilst the catering service provides the majority of the energy intake it 
falls short of providing patient's energy requirements. The ward snacks arrangement 
was designed to supplement the hospital catering provision but this audit shows that 
it fails in this task. 
• Hypovitaminosis A in a child with Cystic Fibrosis 
J. Lowdon, I.J.M. Doull. CF Unit, The Children~' Hospital for Wales', Cardif/, UK 
Introduction: Patients with CF may have vitamin A deficiency due to maldigestion 
and malabsorbtion, aswell as poor compliance with vitamin supplementation. As 
well as clinical manifestations of vitamin deficiencies, low vitamin levels have also 
been associated with compromised clinical status1 and reduced lung function2. 
Patient: An 11 year old male with CF, who has frequent pulmonary infections, re- 
sected bowel due to meconium ileus presentation, liver disease and poor compliance 
with vitamin and pancreatic enzyme treatment, presented with a history of night 
blindness. Previous vitamin A levels had been low (0.06 gmols/1). Attempts had 
been made to correct his by increasing the vitamin A supplementation (5000 IU). 
Results: Opthamology examination revealed a right relative papillary defect with 
poor visual fields on the right and colour vision absent on the right. He had 
bilateral pallor of optic nerves and a faint hypopigmentation f fundus in the 
peripherary. Discussion: Immediate, initial treatment is intramuscular dministration 
of vitamin A in a dose of 100 000 IU of retinol daily for three days. Half the dose 
was then given orally in an oil solution daily for 2 weeks. A marked improvement 
was noted. 
Conclusion: Adequate supplementation, with regular monitoring and prompt action 
on low levels, is essential to prevent co morbidity due to vitamin A deficiency, 
especially in patients with additional risk factors such as a resected bowel. 
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